Cell Cycle News & Views
The Herculean task of killing cancer cells: Suppression of FOXO3A in acute leukemia involves a hydra of multiple survival kinases
Downloads and Tools
Volume 11, Issue 14 July 15, 2012
Page 2589
http://dx.doi.org/10.4161/cc.21233
Authors: Peter P. Ruvolo
View affiliations Hide affiliations
- Peter P. Ruvolo
-
Corresponding author: pruvolo@mdanderson.org
Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston, TX USA
Abstract:
Comment on : Buontempo F, et al. Cell Cycle 2012; 11:2467-75.
Cell Cycle News & Views to:
F Buontempo, F Chiarini, D Bressanin, G Tabellini, F Melchionda, A Pession, M Fini, LM Neri, JA McCubrey, AM Martelli. Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: Involvement of FOXO3a. Cell Cycle 2012; 11: 2467-75
PMID: 22713244 DOI: 10.4161/cc.20859
Received: June 7, 2012; Accepted: June 7, 2012
Preview: